3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Pituitary Neoplasms
4
Nelson Syndrome
2
Multiple Myeloma
2
Carcinoma, Hepatocellular
2
Carcinoid Tumor
2
ACTH Syndrome, Ectopic
2
Uveal Melanoma
1
Thyroid Neoplasms
1
Small Cell Lung Carcinoma
1
Serotonin Syndrome
1
Sarcoma, Synovial
1
Prostatic Neoplasms
1
Prolactin-Producing Pituitary Tumor
1
Primary Inoperable Thymoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pituitary ACTH Hypersecretion
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neuroectodermal Tumors, Primitive
1
Neoplasms
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Meningioma
1
Lymphoma
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Insulinoma
1
Hyperinsulinism
1
Interventions
Etoposide
5
Doxorubicin
5
Vincristine
4
Ifosfamide
4
Cyclophosphamide
4
Filgrastim
3
fludarabine phosphate
2
Thiotepa
2
Tacrolimus
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Melphalan
2
Injections
2
Cyclosporine
2
Carboplatin
2
thymoglobulin
1
temsirolimus
1
spartalizumab
1
pazopanib
1
pasireotide
1
exatecan
1
Topotecan
1
Temozolomide
1
Taxes
1
Surgical Procedures, Operative
1
Sunitinib
1
Stem Cell Transplantation
1
Sorafenib
1
Sirolimus
1
Radiotherapy, Intensity-Modulated
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Desmoplastic Small Round Cell Tumor
×
pasireotide
×
Clear all
NCT06456359
2025-01-13
PAMSARC
University Hospital Heidelberg
Phase 2
Recruiting
28 enrolled